CSE: UDOC | FRA: L7T | OTCQB: UDOCF
Investor
Presentation
Click To
Download
Investor Presentation
Click To
Download
News
Alerts
Click To
Sign Up
News Alerts
Click To
Sign Up

FEATURED PARTNER

With Intel Inside

PARTNERSHIPS

unidoc-partnerships-hp-intel-v01
unidoc-partnerships-docbox-v01
unidoc-partnerships-amd-v01
unidoc-partnerships-dedalus-v01
unidoc-partnerships-medi-orbis-v01
unidoc-partnerships-carefluence-v01
EGS-Health

AI Powered Health

The future of healthcare just got smarter.

By blending artificial intelligence* algorithms with state-of-the-art diagnostics, high-speed access, and high-definition communications equipment, eHealth connects doctors, clinicians, and patients and enables them to access high-quality care in innovative new ways.

*The use of NEIL Connect allows for the integration of advanced AI, through partnered software abilities. Advanced AI refers to advanced artificial intelligence – the ability of the software to provide recommendations personalized to an individual’s needs. NEIL Connect can be integrated with the MediOrbis platform (AI used for patient intake/triage) and the DocBox platform (AI used for patient monitoring).

AI Powered Health

The Future of healthcare just got smarter.

By blending artificial intelligence* algorithms with state-of-the-art diagnostics, high-speed access, and high-definition communications equipment, eHealth connects doctors, clinicians, and patients and enables them to access high-quality care in innovative new ways.

*The use of NEIL Connect allows for the integration of advanced AI, through partnered software abilities. Advanced AI refers to advanced artificial intelligence – the ability of the software to provide recommendations personalized to an individual’s needs. NEIL Connect can be integrated with the MediOrbis platform (AI used for patient intake/triage) and the DocBox platform (AI used for patient monitoring).

The North American market is ready for powerful disruption.

Market Demand

Two thirds of patients are ready to upgrade to virtual care, with 8% already having tried it.

SOURCE

70% of Canadians believe virtual
care represents the future.

SOURCE
$ 0 B
The US eHealth Market is estimated to grow from USD $8.3B in 2019 to USD $476.3B in 2032.
SOURCE

Our Answer is…

UniDoc Virtual eHealth Clinics.

Tightly integrated with real-time capabilities, our eHealth technology is being developed to connect doctors, clinicians and patients. This enables a kind of high quality care that has never before been possible.

We aim to offer a complete
eHealth solution.

Our Platform

*The use of NEIL Connect allows for the integration of advanced AI, through partnered software abilities. Advanced AI refers to advanced artificial intelligence – the ability of the software to provide recommendations personalized to an individual’s needs. NEIL Connect can be integrated with the MediOrbis platform (AI used for patient intake/triage) and the DocBox platform (AI used for patient monitoring).

Better access to
healthcare is the future.

VIEW INVESTOR INFORMATION

LATEST NEWS

Corporate

UniDoc Announces LIFE Offering

April 4, 2025
Read More →
Corporate

UniDoc Announces Debt Settlement and Renews Marketing Engagement

April 3, 2025
Read More →
Corporate

UniDoc Completes Purchase of AGNES Connect® Software from AMD Telemedicine

March 28, 2025
Read More →
VIEW ALL NEWS
CSE: UDOC | FRA: L7T | OTCQB: UDOCF
Investor Presentation

Subscribe to News Alerts

By submitting the form, you agree to receive communications from UniDoc Health.

Consent*

UniDoc Health Corp. © 2025. All rights reserved.

Sign Up For News Alerts

Enter your details below and we will add you to our News Alerts list.

Consent(Required)

Austin Thornberry

Director

Mr. Thornberry is a seasoned finance professional with a background in advising new companies in the venture capital market. He brings extensive experience working with high-growth companies across numerous industries through his past work in the technology and innovation banking group at the Bank of Montreal and in the financial services arm of Ernst & Young advising on multiple capital markets transactions. Mr. Thornberry has split his time working in Toronto, Ont., and Vancouver, B.C. He obtained his bachelor of commerce at McGill University and has held the CPA, CA, designation since 2019.

Matt Chatterton

DIRECTOR

Mr. Chatterton brings over 18 years of experience in development and execution of complex projects. His  expertise includes project management, facility management, logistics, and supply side processes and  procedures at a number of operations in Canada and internationally. He has  been involved in the public markets for the last three years managing IPO processes and transitioning  businesses to post listing operations. Mr. Chatterton is a Professional Engineer and graduate of  Canada’s Queens University with a Bachelor’s degree in Engineering Chemistry (2001) and Master’s degree in Chemical Process Engineering (2003).

Sina Pirooz

Director

Mr. Pirooz is a registered and practicing pharmacist, and has been a professional member of the College of Pharmacists of British Columbia since 2003, with over 20 years of pharmaceuticals and pharmacy management experience. As owner of a compounding pharmacy, Mr. Pirooz has been dispensing pharmaceuticals for over 18 years and provides pharmacist and pharmacy management services to many of Canada’s largest pharmacy chains and drug stores. Mr. Pirooz is also the CEO and a director of Genix Pharmaceuticals Corporation, a company listed for trading on the TSXV.

Dr. Sazzad Hossain, PhD

Chief Scientific Officer

He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.

Jacob Moshinsky

Chief Operating Officer

Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.

Antonio Baldassarre

CEO, President and Director

Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels.

Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value.

Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.

Franco Staino

DIRECTOR

Mr. Franco Staino is a business professional with over 40 years experience in the pharmaceutical industry. Mr. Staino has significant experience in drug safety, traceability and anti-counterfeiting measures and has designed and implemented programs for the Italy National Health Service, the Ministry of Health and the Polygraphic Institute and State Mint.

Mr. Staino currently holds multiple positions including being the control representative of Carlucci a leading company engaged in the production of self-adhesive labels for consumer goods with high specialization for the pharmaceutical sector, and President of the Board of Directors of Topharmacia, a company that deals with the integral management of pharmacies throughout Italy in order to improve their ability to provide social and commercial services, to connect industrial marketing policy to that of the pharmacy, to offer tools in able to guarantee the financial balance of the companies involved.